Leave Your Message

IZIFUNDO ZEXEKO ZAMHLANJE

I-FUCASO: Unyango lwe-BCMA CAR-T yoMntu ngokuPheleleyo ngokuSebenza ngoKusebenza kunye noKhuseleko.I-FUCASO: Unyango lwe-BCMA CAR-T yoMntu ngokuPheleleyo ngokuSebenza ngoKusebenza kunye noKhuseleko.
01

I-FUCASO: Unyango lwe-BCMA CAR-T yoMntu ngokuPheleleyo ngokuSebenza ngoKusebenza kunye noKhuseleko.

2024-07-23

I-FUCASO lutshintsho lwe-BCMA-ejolise kunyango lwe-CAR-T yi-IASO BIO, enikezela ngokusebenza okungenakulinganiswa kunye nokhuseleko lwe-myeloma ephindaphindayo okanye echasayo. Ngamazinga aphezulu okuphendula, ukuxolelwa okuhlala ixesha elide, kunye neprofayili ekhuselekileyo yokhuseleko, i-FUCASO inikeza ithemba elitsha kwizigulane kwaye ibeka umgangatho omtsha kwi-CAR-T yonyango.

jonga iinkcukacha
Isishwankathelo esiBanzi seGroundbreaking Leukemia TreatmentIsishwankathelo esiBanzi seGroundbreaking Leukemia Treatment
01

Isishwankathelo esiBanzi seGroundbreaking Leukemia Treatment

2024-04-22

I-CAR-T Therapy, imfutshane kwi-Chimeric Antigen Receptor T-Cell Immunotherapy, yindlela yonyango yemfuza ehamba phambili ebandakanya ukuguqulwa kofuzo kwiiseli ze-T zesigulane ukujolisa nokutshabalalisa iiseli zomhlaza. Ngokungafaniyo namayeza esintu, unyango lwe-CAR-T lulungiselelwe isigulane ngasinye kwaye lufuna ukuqokelela iiseli ze-T egazini lesigulana ngaphambi kokuba ziphinde zibuyiselwe emzimbeni emva kobunjineli bemfuza.

jonga iinkcukacha